Is AOD-9604 Legal in Alabama? How to Access It Legally
Print or save as PDFOpens the printable question sheet and your print dialog. No sign-up.
At a glance
- FDA approval / None; AOD-9604 never reached approval [1][2]
- FDA compounding lists / In no category on FDA's lists for pharmacies or outsourcing facilities [4][5][6]
- FDA safety concerns / Immunogenicity risk, limited safety information, serious adverse events of unclear causality [3]
- HHS peptide policy / Not one of the six peptides covered [7][8]
- GRAS / No AOD-9604 entry in FDA's GRAS Notice Inventory; the "GRAS" claim traces to a developer-commissioned panel, not FDA [9]
- Sport / WADA prohibits it at all times [10]
- Prescription product / No FDA-approved AOD-9604 product exists [1][2]
What is AOD-9604?
AOD-9604 is a 16-amino-acid piece of human growth hormone: hGH amino acids 177 to 191 with an extra tyrosine added at the front, also called hGH fragment 176-191 [11]. It is not full-length growth hormone [11]. Metabolic Pharmaceuticals developed it as an anti-obesity candidate, with phase IIa trials underway by February 2002; it never reached approval and the obesity program was later dropped [1][2].
Is there an FDA-approved AOD-9604 product?
No. There is no FDA-approved AOD-9604 product to prescribe [1][2]. It also has no entry in FDA's GRAS Notice Inventory, so there is no FDA no-questions letter for it [9].
Can a pharmacy compound it for an Alabama patient?
FDA's page on bulk substances that may present significant safety risks (content dated 04/22/2026) lists AOD-9604 in its nominated-but-withdrawn table, which holds substances previously in category 2 whose nominators withdrew them [3]. FDA's stated concerns are immunogenicity risk for certain routes of administration from peptide impurities and characterization problems, little or no safety information, and serious adverse events that may be associated with AOD-9604 though causality is not clear; removal from category 2 was not a finding that it is safe [3].
AOD-9604 appears in none of the three categories on FDA's list for state-licensed pharmacies and physicians (updated May 14, 2026) or on FDA's list for outsourcing facilities (updated March 21, 2025), and FDA's category 1 policy does not cover it [4][5][6]. HHS's draft enforcement-discretion policy for compounded peptides, filed October 28, 2026, names six substances - BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 - and AOD-9604 is not among them [7][8]. It circulates on the gray market: Belgian authorities and US investigators have found it in seized or confiscated vials [12][11].
What does Alabama law say?
We found no Alabama statute or Board of Pharmacy rule that names AOD-9604. That does not override its federal position described above: no approved product, no FDA compounding category, and FDA's stated safety concerns.
What people on Reddit report
Reddit discussion of the Alabama medical board's warning on non-FDA-approved and research-grade peptides, with people debating whether 'research grade' sales avoid prescription rules.
No he means that the whole point of buying things that are research grade is that because they're not supposed to be for human consumption you can access them without a prescription. That's how the whole market currently operates as a grey market.Read the source discussion
Research grade is really a misnomer but whatever because actually it means stuff explicitly sold not for human consumption / use. So "research grade" doesnt mean what you think it means.Read the source discussion
The whole point of "research grade" is that you don't need a script.Read the source discussion
Questions worth asking
Is AOD-9604 banned in sport?
Yes. WADA's Prohibited List names AOD-9604 and hGH 176-191 in section S2.2.3, growth hormone fragments, prohibited at all times in and out of competition, and it stays on the 2027 List [10][13].
What do the human data show?
A 2026 review describes a 24-week oral anti-obesity study (502 randomized) in which AOD9604 failed to show a significant benefit on the primary weight-loss endpoint, and notes that this conclusion rests on sponsor-reported phase 2 results rather than peer-reviewed randomized trials [2]. A separate 2026 review of unapproved peptides concludes that many look favorable in animals while rigorous human safety data are scarce and serious harm is possible [14].
Check what you know
Score: 0 right, 0 of 5 answered
Frequently asked questions
Is AOD-9604 legal in Alabama?
Can an Alabama pharmacy compound AOD-9604?
Why do some websites say AOD-9604 is GRAS?
Did AOD-9604 work in human trials?
Is AOD-9604 prohibited for athletes?
What people actually ask
Can you take AOD-9604 orally?
Oral use is not established as lawful or safe for AOD-9604. A 2026 review describes a 24-week oral anti-obesity study in which it failed to show a significant benefit on the primary weight-loss endpoint, and FDA's stated concerns include immunogenicity risk for certain routes of administration.
Is peptide AOD-9604 FDA-approved?
No. AOD-9604 never reached approval, and no FDA-approved AOD-9604 product exists to prescribe. It also has no entry in FDA's GRAS Notice Inventory, so there is no FDA no-questions letter for it.
References
- Wilding J. AOD-9604 Metabolic. Curr Opin Investig Drugs. 2004;5(4):436-40. AOD-9604 Metabolic
- Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol (Lausanne). 2026;17:1822475. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA
- U.S. Food and Drug Administration. U.S. Food and Drug Administration
- U.S. Food and Drug Administration. U.S. Food and Drug Administration
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA. Bulk Drug Substances Used in Compounding of the FD&C Act | FDA
- Official web page. Official web page
- Official web page. Official web page
- GRAS Notices. GRAS Notices
- World Anti-Doping Agency. World Anti-Doping Agency
- Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D. Detection and in vitro metabolism of AOD9604. Drug Test Anal. 2015;7(1):31-8. Detection and in vitro metabolism of AOD9604
- Vanhee C, Moens G, Deconinck E, De Beer JO. Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604. Drug Test Anal. 2014;6(9):964-8. Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604
- World Anti-Doping Agency. World Anti-Doping Agency
- Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026;56(8):1921-1935. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
- Reddit participants. Alabama Board of Medical Examiners warns that "under no circumstances is it permissible for a physician to compound, administer, or dispense (r/medicine). Accessed 2026-11-11.